Publication | Closed Access
Randomized Phase III Trial of Single-Agent Pemetrexed Versus Carboplatin and Pemetrexed in Patients With Advanced Non–Small-Cell Lung Cancer and Eastern Cooperative Oncology Group Performance Status of 2
237
Citations
6
References
2013
Year
Combination chemotherapy with CP significantly improves survival in patients with advanced NSCLC and ECOG PS of 2.
| Year | Citations | |
|---|---|---|
Page 1
Page 1